| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | 0.0054 | 0.9 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | ATRA | FIMM | pan-cancer | AAC | 0.023 | 0.9 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | 0.0059 | 0.9 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | 0.026 | 0.9 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | 0.0085 | 0.9 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | -0.0048 | 0.9 |